Fairmount Funds Management LLC, Director at Cogent Biosciences, holds 5.50M shares in Cogent Biosciences (Ticker: COGT), holds 400.98K shares in Apogee Therapeutics (Ticker: APGE), holds 2.75M shares in Crescent Biopharma (Ticker: CBIO). Most recently, Fairmount Funds Management LLC Sold ― shares of Cogent Biosciences on Jan 22, 2026 for an estimated value of $127.40M.
What was Fairmount Funds Management LLC’s latest transaction?
Fairmount Funds Management LLC latest transaction was an Informative Sell of $127.40M.
What was Fairmount Funds Management LLC's most profitable transaction?
Fairmount Funds Management LLC’s most profitable transaction was an Informative Buy of COGT stock on July 14, 2025. The return on the trade was 220.70%.
What is Fairmount Funds Management LLC's role in Cogent Biosciences?
Fairmount Funds Management LLC's role in Cogent Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.